PT DOAC

Specialized reagent panel for monitoring direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban) in patient plasma. Enables accurate coagulation assessment in anticoagulated patients.

A Point-of-Care (POC) testing device for the evaluation of direct oral anticoagulant (DOAC) patients. It is part of the growing family of devices designed to monitor oral anticoagulation therapy.

Complete portfolio for direct oral anticoagulant testing. Enables monitoring of DOAC therapy and assessment of anticoagulation status.

Specific reagent for monitoring dabigatran concentration in anticoagulated patients. Enables accurate DOAC level assessment in coagulation laboratories.

Coagulation reagents for in vitro diagnostic testing on automated coagulation analyzers. These reagents enable rapid measurement of blood clotting parameters including PT, aPTT, and fibrinogen levels. ISO 13485 certified formulations support clinical assessment of hemostasis and thrombotic disorders in laboratory settings.

A whole blood coagulation test reagent card for measuring PT-INR parameters. The dry reagent card is supplied in single aluminum packs containing 50 sheets per package along with a lot card. It requires only 25 μL of sample, enabling measurement of neonatal samples, and uses optical tracking of viscosity changes to detect coagulation endpoints. Calibration is registered via 2D barcode scanning.

A ready-to-use liquid reagent for prothrombin time testing, part of the comprehensive coagulation four-factor panel meeting laboratory requirements for hemostasis and thrombosis screening and diagnosis.

Diagnostic reagent for prothrombin time evaluation using optical clotting methodology. Compatible with automated coagulation analyzers supporting whole blood and plasma analysis.

Specialized reagents for coagulation testing including prothrombin time and activated partial thromboplastin time measurements. Essential for hemostasis assessment and monitoring anticoagulation therapy.

A portable point-of-care thromboelastography platform for rapid platelet function and hemostasis assessment in emergency departments, clinics, operating rooms, and ICUs. This device helps clinicians quickly understand patient hemostatic status and assists in real-time decision-making for treatment strategies. The analyzer enables rapid assessment of bleeding risk and guides appropriate antiplatelet therapy selection.

Specialized thromboplastin reagent for coagulation testing and anticoagulant therapy monitoring. Provides standardized measurement of clotting function.

Rapid POCT coagulation assay for emergency and acute care settings. Provides quick assessment of bleeding risk and coagulation status in trauma and acute illness scenarios. Supports rapid clinical decision-making in time-critical situations.